Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
191 INR | +0.53% | -0.44% | -7.86% |
Jan. 18 | Nath Bio-Genes Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
2023 | Transcript : Nath Bio-Genes Limited, Q2 2024 Earnings Call, Oct 17, 2023 |
Sales 2022 | 2.78B 33.35M | Sales 2023 | 3.01B 36.1M | Capitalization | 2.68B 32.16M |
---|---|---|---|---|---|
Net income 2022 | -673M -8.06M | Net income 2023 | 350M 4.19M | EV / Sales 2022 | 1.78 x |
Net Debt 2022 | 888M 10.64M | Net Debt 2023 | 672M 8.05M | EV / Sales 2023 | 1.11 x |
P/E ratio 2022 |
-6.02
x | P/E ratio 2023 |
7.67
x | Employees | 433 |
Yield 2022 |
0.94% | Yield 2023 |
1.42% | Free-Float | 50.8% |
Latest transcript on Nath Bio-Genes (India) Limited
1 day | +0.53% | ||
1 week | -0.44% | ||
Current month | +9.96% | ||
1 month | +4.86% | ||
3 months | -7.68% | ||
6 months | -3.31% | ||
Current year | -7.86% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 99-08-29 | |
Director of Finance/CFO | 63 | - | |
Compliance Officer | 30 | 18-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 99-08-29 | |
Director/Board Member | 60 | 12-10-09 | |
Director/Board Member | 42 | 15-03-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 191 | +0.53% | 3 671 |
24-04-18 | 190 | +1.09% | 4,899 |
24-04-16 | 188 | 0.00% | 3,278 |
24-04-15 | 188 | -4.06% | 10,830 |
24-04-12 | 196 | +2.11% | 3,576 |
Delayed Quote Bombay S.E., April 19, 2024 at 06:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+11.38% | 3.21B | |
-95.58% | 1.61B | |
-0.37% | 1.53B | |
-1.97% | 1.26B | |
-9.51% | 1.23B | |
-11.06% | 1.21B | |
-.--% | 1.19B | |
0.00% | 1.19B | |
+4.93% | 1.13B |
- Stock Market
- Equities
- NATHBIOGEN Stock
- NATHBIOGEN Stock